Evidence map›Paper›PMID 16707781›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2006

Small, nonpeptide p75NTR ligands induce survival signaling and inhibit proNGF-induced death.

Stephen M Massa, Youmei Xie, Tao Yang, Anthony W Harrington, Mi Lyang Kim, Sung Ok Yoon, Rosemary Kraemer, Laura A Moore, Barbara L Hempstead, Frank M Longo

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 177 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Toward an NGF-based therapy for Rett syndrome.Frontiers in neuroscience · 2026
    Review
  9. Article
  10. Small-Molecule Trk Agonists: Where Do We Go from Here?Journal of medicinal chemistry · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Small molecule modulation of p75Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Stephen M MassaDepartment of Neurology, San Francisco Veterans Affairs Medical Center, San Francisco, California 94121, USA. Stephen.Massa@ucsf.edu
Youmei Xie
Tao Yang
Anthony W Harrington
Mi Lyang Kim
Sung Ok Yoon
Rosemary Kraemer
Laura A Moore
Barbara L Hempstead
Frank M Longo
The Ohio State University · USCornell University · USSan Francisco VA Medical Center · USStanford University · US

Funding

Role of Neurotrophins and Receptors in NeurogenesisR01NS030687 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HEMPSTEAD, BARBARA L · 1993 to 2014
$5.1M
Crosstalk between NGS Receptors, TrkA &P75R01NS039472 · NINDS · OHIO STATE UNIVERSITY · PI YOON, SUNG OK · 2000 to 2009
$3.0M
NINDS NIH HHS NS30687NINDS NIH HHS NS39472
6 · The paper itself

Abstract

Studies showing that neurotrophin binding to p75NTR can promote cell survival in the absence of Trk (tropomyosin-related kinase) receptors, together with recent structural data indicating that NGF may bind to p75NTR in a monovalent manner, raise the possibility that small molecule p75NTR ligands that positively regulate survival might be found. A pharmacophore designed to capture selected structural and physical chemical features of a neurotrophin domain known to interact with p75NTR was applied to in silico screening of small molecule libraries. Small, nonpeptide, monomeric compounds were identified that interact with p75NTR. In cells showing trophic responses to neurotrophins, the compounds promoted survival signaling through p75NTR-dependent mechanisms. In cells susceptible to proneurotrophin-induced death, compounds did not induce apoptosis but inhibited proneurotrophin-mediated death. These studies identify a unique range of p75NTR behaviors that can result from isolated receptor liganding and establish several novel therapeutic leads.

Indexed as

AnimalsAnimals, NewbornApoptosisCell SurvivalDrug Evaluation, PreclinicalHippocampusIsoleucineLigandsMiceMolecular StructureMolecular WeightMorpholinesNerve Growth FactorNerve Growth FactorsNeuronsNeuroprotective AgentsIsoleucineLigandsLM11A-31MorpholinesNerve Growth FactorNerve Growth FactorsNeuroprotective Agentspro-nerve growth factor, mouseProtein PrecursorsReceptor, Nerve Growth Factor

Identifiers

PMID16707781
PMCPMC6675309
OpenAlexW1979022435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.